Suzanne Norris

Author PubWeight™ 32.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1. Clin Infect Dis 2012 2.16
2 Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 2002 2.00
3 Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. J Hepatol 2003 1.58
4 Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV. J Infect Dis 2007 1.31
5 Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection. J Hepatol 2002 1.22
6 Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak. Hepatology 2011 1.14
7 Liver transplantation for HCV-related cirrhosis in a patient with gastric mucosa-associated lymphoma (MALToma) pretreated with rituximab. Liver Transpl 2005 1.08
8 Upper gastrointestinal bleeding: predictors of risk in a mixed patient group including variceal and nonvariceal haemorrhage. Eur J Gastroenterol Hepatol 2012 1.04
9 Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection. Gut 2011 1.01
10 HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C. Hepatology 2006 0.92
11 Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity 2002 0.91
12 Distinct subpopulations of gamma delta T cells are present in normal and tumor-bearing human liver. Clin Immunol 2004 0.86
13 Expression of hereditary hemochromatosis C282Y HFE protein in HEK293 cells activates specific endoplasmic reticulum stress responses. BMC Cell Biol 2007 0.86
14 Risk factors for the development of depression in patients with hepatitis C taking interferon-α. Neuropsychiatr Dis Treat 2011 0.86
15 Effect of iron overload on glucose metabolism in patients with hereditary hemochromatosis. Metabolism 2009 0.85
16 Endoplasmic reticulum stress--a double edged sword for Z alpha-1 antitrypsin deficiency hepatoxicity. Int J Biochem Cell Biol 2008 0.85
17 Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis. J Hepatol 2002 0.84
18 Hepatic expression of IL-15 mRNA is associated with liver graft acceptance. Transpl Immunol 2003 0.84
19 Gallbladder wall variceal haemorrhage with associated rupture: a rare cause of mortality in the cirrhotic patient. Eur J Gastroenterol Hepatol 2009 0.83
20 Glucose metabolism after normalization of markers of iron overload by venesection in subjects with hereditary hemochromatosis. Metabolism 2010 0.83
21 Phenotypic characterization of lymphocytes in HCV/HIV co-infected patients. Viral Immunol 2009 0.81
22 Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype-1-infected individuals. Antivir Ther 2015 0.81
23 Hepatitis B virus genotype A and D and clinical outcomes of liver transplantation for HBV-related disease. Liver Transpl 2004 0.79
24 Interferon-α suppressed granulocyte colony stimulating factor production is reversed by CL097, a TLR7/8 agonist. J Gastroenterol Hepatol 2010 0.78
25 Abdominal rash after transarterial chemoembolization via the right inferior phrenic artery. J Vasc Interv Radiol 2005 0.77
26 Localization of T and B lymphocytes in histologically normal adult human donor liver. Hepatogastroenterology 2003 0.77
27 Hereditary hemochromatosis should be considered a conformational disorder. Med Hypotheses 2007 0.77
28 Mitochondrial toxicity associated with HAART following liver transplantation in an HIV-infected recipient. Liver Transpl 2004 0.76
29 In vitro blood cell responsiveness to IFN-α predicts clinical response independently of IL28B in hepatitis C virus genotype 1 infected patients. J Transl Med 2014 0.76
30 Liver stiffness changes during meal times. Hepatology 2014 0.76
31 Reply to Calcagno et al. Clin Infect Dis 2013 0.75
32 Tauroursodeoxycholic acid: relieving the pathogenesis of HFE C282Y hereditary hemochromatosis. Hepatology 2008 0.75
33 Hepatitis C (chronic). BMJ Clin Evid 2010 0.75
34 Hematochezia in a patient with liver cirrhosis. World J Emerg Surg 2007 0.75
35 Hepatitis C (chronic). BMJ Clin Evid 2007 0.75
36 Hepatitis C (chronic). Clin Evid 2006 0.75
37 Chronic hepatitis C. Clin Evid 2005 0.75
38 Increased Frequencies of Circulating IFN-γ-Producing Vδ1(+) and Vδ2(+) γδ T Cells in Patients with Asymptomatic Persistent Hepatitis B Virus Infection. Viral Immunol 2015 0.75